$KHOB
KHEOBA CORP.

2023 Q4 Form 10-K Financial Statement

#000147793224000458 Filed on January 30, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $16.00K
YoY Change 300.0%
Cost Of Revenue
YoY Change
Gross Profit $16.00K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $583.00
YoY Change
% of Gross Profit 3.64%
Operating Expenses $16.05K
YoY Change 28.43%
Operating Profit -$47.00
YoY Change -99.45%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$47.00
YoY Change -99.45%
Net Earnings / Revenue -0.29%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $16.78K $2.005K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $13.00K $0.00
Receivables
Other Receivables
Total Short-Term Assets $29.78K $2.005K
YoY Change 1385.19%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.917K $3.500K
YoY Change -16.66%
TOTAL ASSETS
Total Short-Term Assets $29.78K $2.005K
Total Long-Term Assets $2.917K $3.500K
Total Assets $32.70K $5.505K
YoY Change 493.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.537K $4.500K
YoY Change -43.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.21K $8.870K
YoY Change 15.07%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.21K $8.870K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$9.412K -$9.365K
YoY Change 0.5%
Common Stock $7.295K $6.000K
YoY Change 21.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.49K -$3.365K
YoY Change
Total Liabilities & Shareholders Equity $32.70K $5.505K
YoY Change 493.91%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income -$47.00
YoY Change -99.45%
Depreciation, Depletion And Amortization $583.00
YoY Change
Cash From Operating Activities -$11.13K
YoY Change 178.52%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $15.10K $25.90K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $25.90K
YoY Change
NET CHANGE
Cash From Operating Activities -$11.13K
Cash From Investing Activities $0.00
Cash From Financing Activities $25.90K
Net Change In Cash $14.77K
YoY Change -469.79%
FREE CASH FLOW
Cash From Operating Activities -$11.13K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001909770
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2024Q1 dei Entity Public Float
EntityPublicFloat
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9365 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3365 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7295000 shares
CY2022Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
7295000 shares
CY2023Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
7295000 shares
CY2021Q3 us-gaap Share Price
SharePrice
0.001
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-263020
CY2023 dei Entity Registrant Name
EntityRegistrantName
KHEOBA CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1636812
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Petonal el Cerezo 8
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
2A Los Realejos
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
38410
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Tenerife
CY2023 dei Entity Address Country
EntityAddressCountry
ES
CY2023 dei City Area Code
CityAreaCode
702
CY2023 dei Local Phone Number
LocalPhoneNumber
833-9604
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8092000 shares
CY2023 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2023 dei Auditor Firm
AuditorFirmId
5525
CY2023 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2023Q4 us-gaap Assets
Assets
32695 usd
CY2022Q4 us-gaap Assets
Assets
5505 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2537 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3300 usd
CY2023Q4 kheo Due To Related Party Current
DueToRelatedPartyCurrent
4370 usd
CY2022Q4 kheo Due To Related Party Current
DueToRelatedPartyCurrent
4370 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10207 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8870 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7295000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6000000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7295 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24605 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9412 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22488 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32695 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5505 usd
CY2023 us-gaap Revenues
Revenues
16000 usd
CY2022 us-gaap Revenues
Revenues
4000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16047 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12495 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
16047 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
12495 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-47 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-8495 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-47 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8495 usd
CY2023 kheo Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
CY2022 kheo Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
CY2023 kheo Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
6088232 shares
CY2022 kheo Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
6000000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5130 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8495 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3365 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25900 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-47 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22488 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-47 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8495 usd
CY2023 us-gaap Depreciation
Depreciation
583 usd
CY2022 us-gaap Depreciation
Depreciation
0 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3300 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1963 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4500 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11127 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3995 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25900 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25900 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14773 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3995 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2005 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16778 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2005 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3300 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7295000 shares
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
9412 usd
CY2023Q4 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
9412 usd
CY2023 us-gaap Revenues
Revenues
16000 usd
CY2023Q4 kheo Due To Related Party Current
DueToRelatedPartyCurrent
4370 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
3500 usd
CY2023Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
3500 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
583 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1167 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1167 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
583 usd
CY2023Q4 kheo Due To Related Party Current
DueToRelatedPartyCurrent
4370 usd
CY2023Q4 kheo Net Operating Loss Carryover
NetOperatingLossCarryover
1977 usd
CY2022Q4 kheo Net Operating Loss Carryover
NetOperatingLossCarryover
1967 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1977 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1967 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
427000 shares
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8540 usd
CY2023Q3 us-gaap Share Price
SharePrice
0.02
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
868000 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17360 usd
CY2023Q4 us-gaap Share Price
SharePrice
0.02
CY2022 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
9365 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9412 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9365 usd
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
0 usd
CY2022 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
0 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
9412 usd

Files In Submission

Name View Source Status
0001477932-24-000458-index-headers.html Edgar Link pending
0001477932-24-000458-index.html Edgar Link pending
0001477932-24-000458.txt Edgar Link pending
0001477932-24-000458-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kheo-20231031.xsd Edgar Link pending
kheo_10k.htm Edgar Link pending
kheo_10kimg1.jpg Edgar Link pending
kheo_10kimg2.jpg Edgar Link pending
kheo_ex311.htm Edgar Link pending
kheo_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
kheo-20231031_cal.xml Edgar Link unprocessable
kheo-20231031_def.xml Edgar Link unprocessable
kheo_10k_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kheo-20231031_lab.xml Edgar Link unprocessable
kheo-20231031_pre.xml Edgar Link unprocessable